Finnegan LP

"Neonatal abstinence syndrome: assessment and pharmacotherapy."
In: Nelson N, editor. Current therapy in neonatal-perinatal medicine. 2 ed. Ontario: BC Decker; 1990.

I➜ The Finnegan's NAS scoring system lists 21 symptoms that are most frequently observed in infants after intrauterine exposure to certain (illicit or prescription) drugs and is used to determine initiation of pharmacologic therapy. These symptoms are most commonly seen in opiate-exposed infants, but also seen after exposure to sedatives, polysubstance abuse, and occasionally barbiturates and alcohol.
The original instrument was designed for term babies on four-hourly feeds and may therefore need modification for preterm infants.

    Related articles :
  • - American Academy of Pediatrics Committee on Drugs (2012). "Neonatal Drug Withdrawal". Pediatrics 2012; 129; e540.
  • - Bio LL, Siu A, and Poon CY. "Update on the pharmacologic management of neonatal abstinence syndrome." Journal of Perinatology (2011) 31, 692-701.
  • - Sie SD et al. "Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation."
    Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F472-6. →PDF

Get Short URL

Never ignore professional medical advice in seeking treatment because of something you have read or use on this site.

Our online tools are addressed to health professionals and not to patients. In any case you may read our complete disclaimer.